Kaposi's Sarcoma clinical trials at UCLA

1 in progress, 0 open to eligible people

sEphB4-HSA in Treating Patients With Kaposi Sarcoma
Sorry, in progress, not accepting new patients
This phase II trial studies recombinant EphB4-HSA fusion protein (EphB4-HSA) in treating patients with Kaposi sarcoma. Recombinant EphB4-HSA fusion protein may block the growth of blood vessels that provide blood to the cancer, and may also prevent cancer cells from growing.
Los Angeles, California and other locations

Last updated: July 16, 2024